Correspondence 0001213900-24-078131 from NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) (CIK 0001500198) (NMTC)
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) (CIK 0001500198)
Date: Sept. 12, 2024 · CIK: 0001500198 · Accession: 0001213900-24-078131
AI Filing Summary & Sentiment
File numbers found in text: 333-281881
Letter
Re: NeuroOne Medical Technologies Corporation
September 12, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, NE
Washington, D.C. 20549
Attention: Jane Park
Registration Statement on Form S-3
File No. 333-281881
Acceleration Request
Requested Date: September 13, 2024
Requested Time: 4:30 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, NeuroOne Medical Technologies Corporation (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 (File No. 333-281881) (as amended, the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon as practicable thereafter, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. The Company hereby authorizes each of Emily J. Johns and Lauren Legner of Honigman LLP, counsel to the Company, to make such request on its behalf.
Please confirm the effectiveness of the Registration Statement with Emily J. Johns of Honigman LLP by telephone at (616) 649-1908 or Lauren Legner of Honigman LLP by telephone at (313) 465-7119.
[Signature page follows]
****
Sincerely,
NeuroOne Medical Technologies
corporation
Show Raw Text
CORRESP
1
filename1.htm
September 12, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, NE
Washington, D.C. 20549
Attention: Jane Park
Re: NeuroOne Medical
Technologies Corporation
Registration Statement on Form S-3
File No. 333-281881
Acceleration
Request
Requested Date: September 13, 2024
Requested Time: 4:30 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the
Securities Act of 1933, as amended, NeuroOne Medical Technologies Corporation (the “Company”) hereby respectfully requests
that the above-referenced Registration Statement on Form S-3 (File No. 333-281881) (as amended, the “Registration Statement”)
be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon as practicable
thereafter, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of
Corporation Finance of the Securities and Exchange Commission. The Company hereby authorizes each of Emily J. Johns and Lauren Legner
of Honigman LLP, counsel to the Company, to make such request on its behalf.
Please confirm the effectiveness
of the Registration Statement with Emily J. Johns of Honigman LLP by telephone at (616) 649-1908 or Lauren Legner of Honigman LLP by telephone
at (313) 465-7119.
[Signature page follows]
****
Sincerely,
NeuroOne Medical Technologies
corporation
/s/ David Rosa
David Rosa
Chief Executive Officer
cc: Emily J. Johns, Honigman LLP
Lauren Legner, Honigman LLP